23:40:01 EDT Fri 12 Jun 2026
Enter Symbol
or Name
USA
CA



Colibri Resource Corp
Symbol CBI
Shares Issued 49,811,010
Close 2011-07-15 C$ 0.26
Market Cap C$ 12,950,863
Recent Sedar+ Documents

Colibri appoints Bartos as director, grants options

2011-07-18 08:35 ET - News Release

Mr. Lance Geselbracht reports

COLIBRI APPOINTS DR. PAUL BARTOS TO BOARD OF DIRECTORS AND GRANTS INCENTIVE STOCK OPTIONS

Colibri Resource Corp. has appointed Dr. Paul J. Bartos as director. Dr. Bartos is a noted authority on epithermal deposits and currently is the vice-president/chief geologist of Esperanza Resources Corp. where he was instrumental in the discovery of the San Luis bonanza vein deposit. This deposit, which was recently sold to Silver Standard Resources, has proven and probable reserves of 503,313 tonnes averaging 17.95 grams per tonne Au, 446.14 g/t Ag (290,484 ounces gold, 7,219,435 ounces silver). San Luis represents one of the highest grade precious metal deposits found in recent years. Prior to this, Dr. Bartos was with ASARCO Inc., with his most recent position as Latin American exploration and business development manager. Among other accomplishments, he was responsible for the discovery and development of the San Bartolome silver deposit in Bolivia. This deposit, containing an estimated 107 million ounces of proven and probable silver reserves, is currently in production by Coeur d'Alene Mines Corp., and is now one of the world's largest pure silver mines.

In welcoming Dr. Bartos, Colibri's chief executive officer Lance Geselbracht said: "Dr. Bartos will be able to provide Colibri with valuable insights as we develop our Ramard silver project and explore our other Sonora, Mexico, properties. His past history in finding and developing orebodies will help guide our exploration work. Paul's experience with a very successful TSX Venture company provides us with additional insight to our own corporate development."

The company also announces that a total of 950,000 options to purchase common shares of the company have been granted to directors and officers at an exercise price of 25 cents per share, expiring on July 17, 2016. Any shares issued on the exercise of these stock options will be subject to a four-month hold period from date of grant. The grant is subject to regulatory approval.

© 2026 Canjex Publishing Ltd. All rights reserved.